Related Articles
The numerous facets of 1q21<sup>+</sup> in multiple myeloma: Pathogenesis, clinicopathological features, prognosis and clinical progress (Review)
Serum miR-30d as a novel biomarker for multiple myeloma and its antitumor role in U266 cells through the targeting of the MTDH/PI3K/Akt signaling pathway
Transient receptor potential channels in multiple myeloma (Review)
Flow cytometry‑based immunophenotypic analysis of primary systemic light chain amyloidosis
The impact of the bone marrow microenvironment on multiple myeloma (Review)